Elle Aon/ShutterstockA recent analysis indicates that HIV cure trials thus far haven’t included enough participants to detect when treatments provide moderate benefits. As a result, researchers may be missing opportunities to study and improve upon drug combinations that could eventually lead to a cure. Dr Jillian Lau, Dr Deborah Cromer and colleagues, whose analysis was published in The Journal of Infectious Diseases, propose a hybrid trial design that would maximise the potential of finding treatment benefits while minimising participant risk.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
[CROI 2026] TheBodyPro: HIV cure research advances by important steps (but no leaps)
-
Medical Xpress: Norway’s ‘Oslo patient’ reaches HIV remission after rare stem cell transplant donated by brother
-
UNC School of Medicine: Researchers demonstrate drug’s effectiveness in drawing out dormant HIV from immune cells
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.